Farmak has exported its own medicinal product to South Africa

Farmak exported its proprietary medicinal product to South Africa (South Africa) for the first time at the end of August, with sales beginning in the autumn.

The medicinal product is for the topical treatment of bacterial conjunctivitis.
The South African market is one of the most regulated in Africa, so the registration procedures for medicinal products are quite lengthy: “Farmak went through the process for 3.5 years. At the same time, this result can be considered ultra-rapid, as the process usually takes up to five years.”
South Africa became the 11th country in Africa and 60th in the world to which Farmak exports its products.